CCS Accelerator Grants

The ability to move cancer research findings into practice, for the benefit of those affected by cancer, is the goal driving most research questions. CCS is not only a cancer research funder, but also plays critical informationsupport and advocacy roles within the Canadian cancer ecosystem, with the goal of saving and improving the lives of people affected by cancer. With the recent launch of the Centre for Cancer Prevention and Support (CCPS), our ability to coalesce research results with our mission work to drive impact more effectively is enhanced. The Canadian Cancer Society’s (CCS) forthcoming research strategy aims to put people at its core and deliver results that will significantly improve the outlook for people affected by cancer in Canada by 2040. To achieve this, we are committed to investing in research that will drive accelerated progress beyond academia, identifying and filling the critical gaps that exist, and applying current knowledge about what we know works.

Important dates:

  • Abstract registrations due May 25, 2022
  • Notification of Relevance results: June 2, 2022
  • Full applications due: July 20, 2022
  • Results announcement: October 2022
  • Anticipated start date: October 15, 2022


  • Funding will be available for:

    -  Up to $100k per synthesis grant over 1-2 yrs (max $50k/yr)

    -  Up to $200k per implementation science grant over 1-2 yrs (max $100k/yr)
  • Up to $1.6M may be awarded in this funding envelope.
  • Funding will be provided to support the direct costs of research, including supplies, expenses, wages, stakeholder engagement (where eligible) (including ceremonial items for feasting and gift-giving for First Nations, Inuit and Métis Peoples), and equipment associated with the proposed work. Indirect costs will not be considered eligible expenses. Permanent equipment requests cannot exceed 10% of requested budget. 

Review CCS’s Financial Administration policy for details of eligible and non-eligible expenses.


The overarching goal of this funding program is to accelerate the application of high-quality evidence that is meaningful to people affected by cancer in the near term (i.e. 2-5 years). In other words, this funding opportunity is intended to stimulate the implementation of evidence-based programs, practices, and policies (i.e. interventions), within 2-5 years, that will improve the lives of people affected by cancer. 

The ultimate objective of an application to this funding opportunity should be to fill a critical gap and demonstrate relevance to a cancer-affected population (people at risk of cancer, patients, caregivers, survivors, etc.). This program requires teams to be inclusive of relevant stakeholders and adopt a co-creation/co-production approach to the research. The application must clearly address the relevant population’s needs and take into consideration  specific intersections (e.g. geographic, economic, racial) as appropriate.

Applications must be relevant to at least one of the following goals:

  1. Preventing cancer in Canada
  2. Detecting and diagnosing cancer earlier in Canada
  3. Enhancing the duration and quality of life for people diagnosed with cancer in Canada
  4. Increasing the number of people in Canada who have equitable access to timely, affordable, and high-quality cancer prevention and/or care

Click here for full list of Eligibility and Requirements 


  1. Review the application guide for step-by-step instructions 
  2. Click here to apply


Agency Name: 
Canadian Cancer Society
Contact Name:
Grant Amount: 
Up to $100k per synthesis grant over 1-2 yrs (max $50k/yr) Up to $200k per implementation science grant over 1-2 years (max $100k/yr)
Grant Location: 
External Deadline: 
Wednesday, July 20, 2022
Internal Deadline: 
Wednesday, July 13, 2022
Grant Type: 
Grant Area: 
Grant Eligibility: